With Robert Christenson
When a patient presents with stroke symptoms, it's important to quickly determine a) if they are indeed having a stroke and b) what type of stroke they are having. If clinicians can quickly answer these questions, they can begin management strategies and therapy in time to potentially improve health outcomes. Unfortunately, the timely assessment of patients with suspected ischemic stroke remains challenging. Brain biomarker assays have the potential, however, to improve early diagnosis of ischemic stroke.
During this informative webinar, you will hear:
~ How stroke is currently classified, diagnosed, and treated
~ The characteristics of an "ideal" biomarker or panel of biomarkers for ischemic stroke
~ What assays currently show promise as potential stroke biomarkers
~ What obstacles must be overcome before these biomarkers can be used clinically
|